Systemic arterial hypertension (SAH) is Brazil’s most prevalent chronic non-communicable disease, commonly aggravated by metabolic disorders, such as diabetes mellitus, dyslipidemia, and obesity. Due to its silent course, research into subclinical injuries in the early stages is essential to establish measures to prevent cardiovascular complications. Risk identification with sensitive markers enables early therapy, reducing morbidity and mortality associated with cardiovascular diseases.

Pulse wave velocity (PWV) is the gold standard for identifying arteriosclerosis. There is a dose-response relationship between increased PWV and the occurrence of major cardiovascular outcomes, such as acute coronary syndrome, cerebrovascular syndromes, and death.

[…]